Abstract
Backgrounds: In patients with acromegaly, sleep apnea-related hypoxemia results in considerable morbidity and mortality. Aims: To evaluate the relative weight of pathogenic factors in predicting such hypoxemia. Methods: In this cross-sectional study, 34 acromegaly patients were submitted to clinical evaluation, nocturnal oximetry, and nasolaryngeal airway tomography. GH, IGF-I, and its upper limit normal value were measured. Nocturnal hypoxemia was defined as >5 episodes of desaturation/h of sleep. Craniofacial abnormalities were expressed using a linear parameter index (LPI). Nocturnal hypoxemia was predicted using logistic regression, including the variables markers of craniofacial abnormality, hormonal alteration, and obesity. Coefficients were standardized in order to determine their effect magnitudes relative to the outcome. The best model included the variables gender, age, LPI, body mass index (BMI), and IGFI upper limit normal value. Main results: In the absence of the age and gender variables, the odds ratio for the LPI (1.60) was slightly higher than those found for BMI (1.49) and upper limit normal value (1.40). When the data were adjusted for age, the hormone upper limit normal value presented little alteration (1.49), although the decrease in the LPI was considerable (1.21), as was the increase in the BMI (2.18). The relative weight of the LPI was age-dependent. The gender variable did not alter the relevance of the others. Conclusions: The effects that craniofacial aspect, obesity, and hormonal alterations have on nocturnal hypoxemia are of similar magnitude.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-yeat followup. Am J Respir Crit Care Med 2002, 166: 159–65.
Rodrigues MP, Casulari LA, Naves LA, Silva CA, Araújo RR, Viegas CA. Using clinical data to predict sleep hypoxemia in patients with acromegaly. Arq Neuropsiquiatr 2007, 65: 234–9.
Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991, 115: 527–32.
Blanco Pérez JJ, Bianco-Ramos MA, Zamarrón Sanz C, Souto Fernández A, Mato Mato A, Lamela López J. Acromegaly and sleep apnea. Arch Bronconeumol 2004, 40: 355–9.
Rosenow F, Reuter S, Deuss U, et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 1996, 45: 563–9.
Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med 1970, 39: 1–16.
Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apneainduced hypoxemia during sleep. Chest 2001, 119: 1085–91.
Ryan CM, Bradley TD. Pathogenesis of obstructive sleep apnea. J Appl Physiol 2005, 99: 2440–50.
Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J, Horinek D. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur J Endocrinol 2001, 144: 491–7.
Hochban W, Ehlenz K, Conradt R, Brandenburg U. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 1999, 14: 196–202.
Chiner E, Signes-Costa J, Arriero JM, Marco J, Fuentes I, Sergado A. Nocturnal oximetry for the diagnosis of the sleep apnoea hypopnoea syndrome: a method to reduce the number of polysomnographies? Thorax 1999, 54: 968–71.
Grunstein RR, Ho KY, Berthon-Jones M, Stewart D, Sullivan CE. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994, 150: 496–502.
Grunstein RR, Ho KK, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994, 121: 478–83.
Ip MS, Tan KC, Peh WC, Lam KS. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 2001, 55: 477–83.
Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H, Mann K. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur Respir J 2004, 151: 309–15.
Buyse B, Michiels E, Bouillon R, Bobbaers H, Demedts M. Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature. Eur Respir J 1997, 10: 1401–4.
Watanabe T, Isono S, Tanaka A, Tanzawa H, Nishino T. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep-disordered breathing. Am J Respir Crit Care Med 2002, 165: 260–5.
Ferguson KA, Ono T, Lowe AA, Ryan CF, Fleetham JA. The relationship between obesity and craniofacial structure in obstructive sleep apnea. Chest 1995, 108: 375–81.
Dostálová S, Sonka K, Smahel Z, Weiss V, Marek J. Cephalometric assessment of cranial abnormalities in patients with acromegaly. J Craniomaxillofac Surg 2003, 31: 80–7.
Isono S, Saeki N, Tanaka A, Nishino T. Collapsibility of passive pharynx in patients with acromegaly. Am J Respir Crit Care Med 1999, 160: 64–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodrigues, M.P., Naves, L.A., Casulari, L.A. et al. Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly. J Endocrinol Invest 31, 1052–1057 (2008). https://doi.org/10.1007/BF03345651
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345651